OTC

Strength

10; 5; 25 mg/5mL; mg/5mL; mg/5mL

NDC

50991022016

Classification

Generic

Dosage Form

LIQUID

Route

ORAL

Last Updated

6/18/2025

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

6/22/2013

Pharmacological Classes

Adrenergic alpha1-Agonists
Sigma-1 Agonist
Sigma-1 Receptor Agonists
Uncompetitive N-methyl-D-aspartate Receptor Antagonist
Uncompetitive NMDA Receptor Antagonists
alpha-1 Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+0.3%

3Y

-0.9%

5Y

-0.9%

All

-2.1%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.